VC

Vibha Chaubey

Active Director Director DIN 02066445
DIN 02066445 First appointment May 1996 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 1996
Shareholding value •••• Premium profile

About Vibha Chaubey

Data last updated:

Vibha Chaubey is a Director at R.Shank Pharma Private Limited (since 1996). The company operates in Trading. R.Shank Pharma Private Limited reported revenue of ₹74.5 Lakh (FY 2025).

DIN 02066445
Primary Designation Director
Industry Trading
First Appointment 22 May 1996
Oldest Company Age 30 yrs
Largest company R.Shank Pharma Private Limited · ₹74.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
R.Shank Pharma Private Limited U24931UP1996PTC019997
Director22 May 19961996₹74.5 Lakh (FY 2025)Active

Board colleagues of Vibha Chaubey

Directorship timeline

Open interactive timeline →
R.Shank Pharma Private Limited
Premium access

Shareholding and investment profile for Vibha Chaubey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vibha Chaubey

Vibha Chaubey currently holds 1 directorship: R.Shank Pharma Private Limited (Director, since 22 May 1996, revenue ₹74.5 Lakh (FY 2025)).

Vibha Chaubey was first appointed on 22 May 1996 as Director at R.Shank Pharma Private Limited.

The current boards of Vibha Chaubey's companies include Ghulam Sarwar (R.Shank Pharma Private Limited), Ravi Shanker Chaube (R.Shank Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available